Differential Subcellular Localization Regulates Oncogenic Signaling by ROS1 Kinase Fusion Proteins
Dana S Neel1,2, David V Allegakoen1,2, Victor Olivas1,2
1Department of Medicine, University of California at San Francisco, San Francisco, California.
Abstract:
Chromosomal rearrangements involving receptor tyrosine kinases (RTK) are a clinically relevant oncogenic mechanism in human cancers. These chimeric oncoproteins often contain the C-terminal kinase domain of the RTK joined in cis to various N-terminal, nonkinase fusion partners. The functional role of the N-terminal fusion partner in RTK fusion oncoproteins is poorly understood. Here, we show that distinct N-terminal fusion partners drive differential subcellular localization, which imparts distinct cell signaling and oncogenic properties of different, clinically relevant ROS1 RTK fusion oncoproteins. SDC4-ROS1 and SLC34A2-ROS1 fusion oncoproteins resided on endosomes and activated the MAPK pathway. CD74-ROS1 variants that localized instead to the endoplasmic reticulum (ER) showed compromised activation of MAPK. Forced relocalization of CD74-ROS1 from the ER to endosomes restored MAPK signaling. ROS1 fusion oncoproteins that better activate MAPK formed more aggressive tumors. Thus, differential subcellular localization controlled by the N-terminal fusion partner regulates the oncogenic mechanisms and output of certain RTK fusion oncoproteins. SIGNIFICANCE: ROS1 fusion oncoproteins exhibit differential activation of MAPK signaling according to subcellular localization, with ROS1 fusions localized to endosomes, the strongest activators of MAPK signaling.
Insights
Receptor tyrosine kinase (RTK) fusions drive cancer. Distinct N-terminal partners alter ROS1 fusion protein location, affecting MAPK signaling and tumor aggression. Endosomal localization enhances oncogenic activity.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Chromosomal rearrangements of receptor tyrosine kinases (RTK) are key oncogenic drivers in human cancers.
- RTK fusion oncoproteins typically consist of the kinase domain fused to a non-kinase N-terminal partner.
- The role of these N-terminal partners in RTK fusion oncoprotein function is largely unknown.
Purpose of the Study:
- To investigate how N-terminal fusion partners influence the subcellular localization and signaling of ROS1 receptor tyrosine kinase (RTK) fusion oncoproteins.
- To determine the impact of differential subcellular localization on the oncogenic properties and MAPK pathway activation of ROS1 fusions.
- To elucidate the clinical relevance of N-terminal partner-mediated regulation of RTK fusion oncoprotein activity.
Main Methods:
- Generated and characterized distinct ROS1 fusion oncoproteins (SDC4-ROS1, SLC34A2-ROS1, CD74-ROS1 variants).
- Utilized cell-based assays to assess subcellular localization (endosomes, ER) and MAPK pathway activation.
- Performed functional studies to correlate subcellular localization with oncogenic potential and tumor aggressiveness.
Main Results:
- N-terminal fusion partners dictated differential subcellular localization of ROS1 oncoproteins.
- ROS1 fusions on endosomes (SDC4-ROS1, SLC34A2-ROS1) robustly activated MAPK signaling.
- CD74-ROS1 variants in the endoplasmic reticulum (ER) showed impaired MAPK activation, which was restored upon forced relocalization to endosomes.
- Enhanced MAPK activation correlated with increased tumor aggressiveness.
Conclusions:
- The N-terminal fusion partner is a critical determinant of subcellular localization for ROS1 RTK fusion oncoproteins.
- Differential subcellular localization modulates MAPK pathway activation and oncogenic output.
- Endosomal localization confers stronger MAPK signaling and promotes more aggressive tumor formation, highlighting a novel mechanism of oncogenic regulation in RTK fusions.
More Related Videos
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
07:18A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening
Published on: May 12, 2017
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Tagging and Fusion Proteins
Nuclear Localization Signals and Import
